Outlook Therapeutics, Inc.OTLKNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank8
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-14.94T
↓ 124% vs avg
Percentile
P8
Near historical low
Streak
1 yr
Consecutive growthContracting
Average
$-6.68T
Historical baseline
PeriodValueYoY Change
TTM$-14.94T+71.2%
2025$-51.83T-75340109.9%
2024$-68.79M-60.1%
2023$-42.97M+24.2%
2022$-56.67M-4.5%
2021$-54.25M-70.7%
2020$-31.79M+1.5%
2019$-32.29M+2.3%
2018$-33.04M-113.1%
2017$-15.51M-